Faglige interesser
Molekylærgenetikk - utviklingsstudier med fokus på kraniofaciale strukturer og immunsystemet
Gruppeleder: Professor Zlatko Dembic, dr. med.; Medlemmer: emeritus prof. Marie Wika, Randi Krog Eftedal, dr. odont.
Vi undersøker genenes betydning for tidlige signaler i utviklingen av embryonale vev til strukturer i det kraniofaciale område - omfattende mucosa, spyttkjertler, tenner, knokler, ledd, tonsiller, beinmarg og nervevev. Vi undersøker også gener som kan predisponere for ulike sykdommer av immunologisk og/eller inflammatorisk karakter og som kan føre til utvikling av kroniske sykdommer senere i et individs liv. Vi benytter ”case” (pasient) – kontroll studier for å bestemme frekvenser av genetiske markører i genetiske områder valgt ut fra kvalifisert gjetning eller knyttet til kraniofaciale områder der mikrochip profiler uttrykkes. Nylig er det gjort en undersøkelse på predisponerende faktorer for tuberkulose, bryst- og coloncancer såvel som primær oseoartritt i store ledd og i temporomandibulærleddet (kjeveleddet). Gener av interesse omfatter cytokinfamilimedlemmer som interferon-gamma og interleukin-1 og Toll-lignende receptor familiene 1,2,3,4,6,7 og 9, som er viktige for tidligaktivering av de spesifikke (adaptive) immunresponsene.
Emneord: 1. DNA, 2. Immungenetikk, 3. Respiratory infection, 4. Epitelial kreft, 5. Ledd inflammasjon, 6. Immunregulation, 7. RT PCR
Undervisning
http://www.uio.no/studier/program/odontologi/
http://www.uio.no/studier/program/medisin/
Bakgrunn
As a scientist with a medical background, it's natural that my research interests are placed at the crossroads of medicine and biology. Since the earliest days of my lab career, I have been attracted to molecular and cellular immunology. The more I learned, the more my interest evolved toward studying ontogeny and phylogeny of the immune system. The reason was simple: I wished to understand its function, which is still my wish. During the last twenty years of the past century, I've worked on important issues in immunology at the Max-Planck-Institute for Biology (Tubingen, Germany), the Basel Institute for Immunology (Switzerland; CH) and the Hoffman-La Roche AG (Basel, CH). We were the first to report the identification of genes underlying T-cell specificity and recognition (mouse T-cell receptor, in '86). Likewise, we led the research on molecular cloning of human cytokine receptors important for the effector phase of immunity, such as the interferon-gamma receptor (IFNGR1; in '88) and the tumor necrosis factor receptor-2 (TNFR2; in '90). 1995, I moved to the Institute of Immunology at the University of Oslo, Norway. Since then, I have broadened the scope of my research by working on T-cell development, cancer immunobiology, immunogenetics and susceptibility to cancer and infectious diseases. And, since 2002, I worked at the Department of Oral Biology, OF, UiO.
This was only possible with a substantial contribution from my academic collaborators and colleagues in Norway and Croatia. Some of these studies led me to propose a model about the workings of the immune system called the "integrity" model in the mid-nineties. It stresses that immunity is a defense system, an active protector of own tissues, and a selector of potential commensals. So far, my publication list has over 100 scientific contributions. Ten percent were published in top scientific journals (Nature and Cell), with me as a prominent author (in half). I have published a monograph about "Cytokines of the Immune System" (Academic Press, Elsevier, 2015). I take these achievements as evidence of the great fun and joy that basic research in immunology has given me over the past years. They are also the source of an unending motivation to study further what remains unknown - a progressively smaller part of the human body.
CURRICULUM VITAE - PERSONAL INFORMATION
Researcher unique identifiers: ORCID ID: 0000-0002-9970-6497
EDUCATION
1977 Dr. med., (M.D.) Medical Faculty, University in Rijeka (UiR), Croatia.
1980 Mr. Sc. in biomedicine, University in Zagreb (UiZ), Croatia.
1987 Dr. sc. in medicine (Ph.D. equivalent), UiR, Croatia.
PREVIOUS POSITIONS
1977 - 1980 Assistant, Department of Physiology, Medical Faculty (MF), UiZ.
1980 - 1984 Research Assistant and Lecturer, Department of Physiology, MF, UiZ,
1982 - 1984 Postdoctoral research fellow, Max-Planck Institut für Biologie, Abt. Immungenetik, Tübingen, Germany
1984 - 1986 Member, Basel Institute for Immunology, Basel, Switzerland
1986 - 1989 Staff Scientist, Hoffmann-La Roche Ltd, Basel, Switzerland
1989 - 1995 Senior Scientist, Hoffmann-La Roche Ltd, Basel, Switzerland
1991 - 2002 Visiting Lecturer, Medical Faculty, University in Rijeka, Croatia
1995 - 1996 Guest Scientist, Institute for General and Rheumatologic Immunology (IGRI), The National Hospital (Rikshospitalet), Oslo, Norway
1997 - 2002 Senior Scientist (Forsker, Den Norske Kreftforening), IGRI / Institute of Immunology, The National Hospital (Rikshospitalet), Oslo, Norway
2002 - 2007 Visiting Associate Professor in medicine (biomedicine), Medical Faculty, UiR, Rijeka, Croatia.
INSTITUTIONAL RESPONSIBILITIES
2002 - present: Course leader: “Cranio-facial developmental biology“, a postgraduate course in the core curriculum of specialists’ education at the Faculty of Dentistry, UiO, Norway.
2012 - 2015 3rd semester leader, Faculties of Medicine, Dentistry and Nutrition, UiO.
2017 Course leader: “Basics of Tumor Immunotherapy “, a postgraduate course as a part of the Medical Oncology study for postgraduates and specialists in medicine at the University of Zagreb, Croatia.
2001 - 2008 Course leader: “Cytokines and disease“, postgraduate course (bi-annual) in “Biomedicine” at the Medical School, University of Rijeka, Croatia.
COMMISSIONS OF TRUST
2001 – 2006 Editor-in-chief, Scandinavian Journal of Immunology; publisher: Blackwell, UK.
2006 – 2021 Associate Editor, Scandinavian Journal of Immunology; publisher: Blackwell Science, Wiley, UK.
2022 – pres. Associate Editor, Cancer immunity and immunotherapy, Frontiers in Immunology; Frontiers in Oncology (Frontiers Media SA).
MEMBERSHIPS OF SCIENTIFIC SOCIETIES
2008 – 2010 President of the Norwegian Society for Immunology
GRANTED PATENTS:
Several patents filed in Switzerland, in European Union and the USA dealing with Cytokines’ receptors and their potential use as hybrid molecules with immunoglobulins, for example:
1. Inventor (with R. Gentz and G. Garotta) of the patent "Chimeric Human Interferon-gamma Receptor - Immunoglobulin Polypeptides" filed by ROCHE, on Mar 1993 (EU);
2. Co-inventor of the US patents "Human TNF Receptor" (US 8,163,522 B1) and “Human TNF Receptor Fusion Proteins” (US 8,063,182 B1) filed by ROCHE, May 19, 1995, of which the latter describes a product known as etanercept. It is a successful biological called Enbrel (Amgen), currently used to treat autoimmune diseases like rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile arthritis and ankylosing spondylitis.
Prizes
The Hoffman-LaRoche prize (internal) for the first report on molecular cloning of the human Interferon gamma receptor molecule (1988)
Collaborations
Medical Faculty, University of Oslo:
Centre for Immune Regulation (CiR) - Professor Bjarne Bogen
Faculty of Medicine, University of Rijeka, Croatia:
Dept of Molecular Medicine and Biotechnology - Professor dr. med. Sinisa Volarevic;
Clinic of Internal Medicine, Dept of Pulmology - Docent dr. med. Ljiljana Bulat-Kardum;
Dept of Physiology - Professor dr. med. Ines Mrakovčić Šutić
Clinic for Orthopaedics, Lovran - Professor dr. med. Zdravko Jotanović
Faculty of Medicine, University "Juraj Dobrila", Pula, Croatia:
General Hospital, Clinic for Oncology - Professor dr med Damir Vrbanec;
Institute Rudjer Boskovic, Zagreb, Croatia:
Dept of Molecular Medicine - Dr Jelena Knezevic,